Financhill
Sell
46

AZTA Quote, Financials, Valuation and Earnings

Last price:
$35.11
Seasonality move :
12.23%
Day range:
$34.72 - $35.87
52-week range:
$23.91 - $55.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.71x
P/B ratio:
0.93x
Volume:
718.2K
Avg. volume:
594.6K
1-year change:
-25.21%
Market cap:
$1.6B
Revenue:
$593.8M
EPS (TTM):
-$1.31

Analysts' Opinion

  • Consensus Rating
    Azenta, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $39.83, Azenta, Inc. has an estimated upside of 13.49% from its current price of $35.10.
  • Price Target Downside
    According to analysts, the lowest downside price target is $34.00 representing 3.13% downside risk from its current price of $35.10.

Fair Value

  • According to the consensus of 5 analysts, Azenta, Inc. has 13.49% upside to fair value with a price target of $39.83 per share.

AZTA vs. S&P 500

  • Over the past 5 trading days, Azenta, Inc. has underperformed the S&P 500 by -3.34% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Azenta, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Azenta, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Azenta, Inc. reported revenues of $159.2M.

Earnings Growth

  • Azenta, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Azenta, Inc. reported earnings per share of $1.02.
Enterprise value:
1.3B
EV / Invested capital:
0.74x
Price / LTM sales:
2.71x
EV / EBIT:
--
EV / Revenue:
2.22x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
34.38x
Price / Operating cash flow:
41.93x
Enterprise value / EBITDA:
28.67x
Gross Profit (TTM):
$270M
Return On Assets:
1.17%
Net Income Margin (TTM):
4.03%
Return On Equity:
1.39%
Return On Invested Capital:
1.35%
Operating Margin:
1.45%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $665.1M $592.4M $594.1M $170.1M $159.2M
Gross Profit $233.3M $245.6M $270M $63M $72.3M
Operating Income -$85.6M -$42.7M -$11.4M -$11M $2.3M
EBITDA -$14K $25.2M $46M $12.8M $16.7M
Diluted EPS -$0.21 -$2.97 -$1.31 -$0.10 $1.02
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $777.4M $2.5B $1.4B $832.8M $709.6M
Total Assets $1.8B $3.7B $2.9B $2.1B $2.1B
Current Liabilities $345.1M $230.5M $210.9M $204.8M $240M
Total Liabilities $494.2M $352.7M $351.2M $331.1M $333.6M
Total Equity $1.3B $3.4B $2.5B $1.8B $1.7B
Total Debt $95.1M $49.4M $62.5M $61M $51.2M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $17.5M $45.9M $72.2M $13.7M $2.2M
Cash From Investing $431.4M $222.1M -$90.5M $195.3M $826K
Cash From Financing -$844.1M -$659.2M -$9.6M -$247.5M $817K
Free Cash Flow -$21.9M $5.8M $38.3M $1.7M -$5.7M
AZTA
Sector
Market Cap
$1.6B
$28.8M
Price % of 52-Week High
63.09%
51.13%
Dividend Yield
0%
0%
Shareholder Yield
0.1%
-1.32%
1-Year Price Total Return
-25.21%
-20.64%
Beta (5-Year)
1.288
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $35.92
200-day SMA
Buy
Level $31.57
Bollinger Bands (100)
Buy
Level 29.16 - 33.22
Chaikin Money Flow
Buy
Level 54.3M
20-day SMA
Buy
Level $32.56
Relative Strength Index (RSI14)
Buy
Level 59.92
ADX Line
Buy
Level 24.67
Williams %R
Neutral
Level -33.0843
50-day SMA
Buy
Level $31.55
MACD (12, 26)
Buy
Level 1.36
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 82.3M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.8607)
Buy
CA Score (Annual)
Level (1.161)
Buy
Beneish M-Score (Annual)
Level (-3.0213)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-6.4345)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Stock Forecast FAQ

In the current month, AZTA has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The AZTA average analyst price target in the past 3 months is $39.83.

  • Where Will Azenta, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Azenta, Inc. share price will rise to $39.83 per share over the next 12 months.

  • What Do Analysts Say About Azenta, Inc.?

    Analysts are divided on their view about Azenta, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Azenta, Inc. is a Sell and believe this share price will drop from its current level to $34.00.

  • What Is Azenta, Inc.'s Price Target?

    The price target for Azenta, Inc. over the next 1-year time period is forecast to be $39.83 according to 5 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is AZTA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Azenta, Inc. is a Hold. 4 of 5 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of AZTA?

    You can purchase shares of Azenta, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Azenta, Inc. shares.

  • What Is The Azenta, Inc. Share Price Today?

    Azenta, Inc. was last trading at $35.11 per share. This represents the most recent stock quote for Azenta, Inc.. Yesterday, Azenta, Inc. closed at $35.10 per share.

  • How To Buy Azenta, Inc. Stock Online?

    In order to purchase Azenta, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 18.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock